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SMethod: Nine coronary artery patients (age: 57.59.6 years) who undergone an
Absorbe BCS (Bioresorbable Vascular Scaffold System, BVS) between November
2012 and June 2013 were enrolled into the study. Chronic total occlusion are deﬁned
by TIMI 0 antegrade ﬂow through the affected segment of >3 months duration.
Patients were recommended to receive a double antiplatelet therapy for at least 12
months, after the implantation process. After each process all patients were clinically
followed for a period of 1., 3., 6., and 12. months periodic clinical follow-ups were
done.
Fındıngs: : As previously planned, scaffold implantation process was successfully
carried out in entire patients. A number of 1.770.83 (min: 1 – max: 3) items of BCS,
with an average length of 45.33  18.02 mm (min:28 mm – max:74 mm) were
implanted to each patient. The mean follow-up period was 3.72.5 months (min:1 –
max:8 months). No any cardiac events were encountered in the remaining 32 patients.
Conclusıon: Bioresorbable coronary scaffolds appear as a safe and effective option in
CTO treatment. When lesion preparation, predilatation is very important in implan-
tation of scaffold to CTO segmnet. To accurately display the anticipated advantages,
larger-scaled and long-term follow-up studies are required.
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Background and Objectõve: In recent years, developed transcatheter aortic valve
implantation (TAVI) has become an alternative for surgery. However, with advanced
age, the several comorbid factors together with contrast agent using that can cause
deterioration in renal functions increases the risk of acute kidney injury (AKI).
Prognosis is poor in patients with AKI. Therefore, many patients cannot beneﬁt from
this treatment. In this study, we aim to examine the effects of TAVI on renal functions.
Methods-Results: 70 patients were performed TAVI between July 2011 and
December 2012. Estimated glomerular ﬁltration rate (eGFR) was calculated by
measuring using the Cockcroft and Gault Formula. Patients were monitored for 48
hours for urine output. The mean age was 77,6 years. Only 5 (%7,1) of the patients
developed stage 1 AKI according to VARC-2 AKIN system after the procedure. There
was a statistically signiﬁcant increase between the patients’ mean 1th month eGFRs
before (68,2 vs 61,0 p:0,005) and after (68,2 vs 63,6 p:0,03) the procedure in the ﬁrst
month. After the procedure (48,5 ml/dk, p:0,004) and ﬁrst month (52,1 ml/dk,
p<0,0001) eGFR of the 36 (%51,4) patients, who were diagnosed with chronic kidney
disease before the procedure, showed a statistically signiﬁcant increase. Hospital
mortality rate was higher with the group which developed AKI (p:0,003). First month
eGFR showed a more statistically signiﬁcant increase than pre-procedure eGFR (62,8
and 69,8 p¼0,04), in AKI developing patients and this difference - though statistically
not signiﬁcant - continued in the sixth month.
Conclusıon: With this study, we showed that the treatment of AS through TAVI
allows improvement for renal functions, and that AKI rates will be lower with careful
patient selection, proper pre-procedural hydration, and carefulC232 JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
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Introduction-objectives: Carotid artery stenting (CAS) process, especially in high-
risk patients, is carotid endarterectomy (CEA) alternative. Our aim in this study, the
reliability of CAS process, to evaluate the clinical and radiological results of the
second year.
Method: 120 patients [mean age 68 (48-86)] who have admitted to our hospital
between December 2010 and March 2013 and CAS decision taken, were included in
the study. Patients with symptomatic carotid artery and 50% of those with stenosis,
patients with asymptomatic carotid artery stenosis greater than 70% were included.
80% of asymptomatic patients, coronary bypass surgery in patients who had pre-
created screen-detected. 75% of symptomatic patients, 81% of coronary artery disease,
64% of hypertensive, was 44% of the diabetic. 81% of male patients in our study
group, the rate of smoking was 40%. Patients were on average 21 months (2-28
months), were followed. All the patients before the procedure, carotid doppler ultra-
sound and patients who require computed tomography (CT) angiography, was per-
formed. Ultrasound, instent peak ﬂow velocity 224 cm/sec and CT angiography in
the detection of stenosis 50% was considered as restenosis. CAS operation, 62% of
patients, proximal-lock braking system (Mo.Ma), 38% in the distal embolic
protection device (Anjioguard) was used. 23% of patients (28 patients) had bilateral
carotid artery stenosis. Of these patients, 19 of them lock braking system proximal,
distal embolic protection device was used in 9 of them. 9 patients (7%) 100% against
the carotid artery was occluded. Distal embolic protection devices were used in these
patients.
Results: One patient (0.8%) 24 hours after treatment, cerebrovascular ischemic events
with sequelae, developed. Patients were followed up for neurology and medical
recommendation. 2 patients (1.7%), 6 and 11 months after treatment of transient
ischemic attack (TIA) is observed. TIA patients undergoing open carotid stents was
observed, in one of these patients with paroxysmal atrial ﬁbrillation was detected and
warfarin medication was started, other patients cranial angiography, intracerebral
lesions in the arteries viewed and neurology clinic with the proposal of a serious
medical follow-up was continued. 3 (2.5%) patients were asymptomatic, 12th month
restenosis were detected with doppler ultrasound scans and conﬁrmed by CT angi-
ography. Two of the patients with restenosis, one of them %60 stent restenosis in
carotid artery, while the other was at the level of 80%. For patient who has 80%
stenosis lesion, CEA procedures were performed. Symptomatic restenosis was not
observed.
Conclusıon: CAS-treated patients in our clinic, the success and complication rates are
similar to other studies.The largest share of low complication and high success rates,
getting experience in our clinic, patient selection and follow-up with neurology and
radiology clinics provide an important contribution are made in the opinion.
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Backgroun and Aim: Atrial ﬁbrillation (AF) is the most common arrhythmia
observed in severe aortic stenosis (AS) and important prognostic indicator for clinicalJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTdeterioration. The difference between maximum and minimum p wave duration
deﬁned as p-wave dispersion (PWD), reﬂecting heterogeneous atrial conduction has
been proposed as being useful for the estimation of AF. The aim of this study was to
evaluate PWD in patients after decreasing left atrium pressure load following trans-
catheter aortic valve implantation (TAVI).
Methods: 60 consecutive patients from 68 to 96 (77,6) years old with severe AS were
enrolled the study. Maximum, minimum P wave duration and PWD were calculated
from 12-lead surface electrocardiograms (ECG) at a rate of 50mm/s before and after
the TAVI. The measurements of the P-wave duration were performed manually by
two of the investigators. To improve accuracy, measurements were performed with
calipers and magnifying lens for deﬁning the ECG deﬂection. P-wave duration was
measurements from the onset to the offset of the P wave. All patients were assessed by
echocardiography to measure left atrium diameter, left ventricle ejection fraction,
max-mean aortic gradient, aortic valve velocity, aort valve area.
Results: All patients had severe AS (max/mean gradients: 85,2/52,8 mmHg, Aortic
valve area: 0.6 cm2, mean left atrium diameter:5.21.2 cm) and high surgical risk
(logistic euroscore: %21,7, STS: 7,7). PWD was correlated with LA diameter and
mean aortic gradient. There was statistically signiﬁcant difference before and after
TAVI in PWD (p<0.001). Patients’ PWD after TAVI (40,723,6; p:0.012) and and
1st week after TAVI (33,222,8; p<0.001) was signiﬁcantly lower than before the
TAVI (46.027.8). Also statistically signiﬁcant difference of PWD was observed
between after TAVI and 1st week after TAVI (p.0.004). AF was seen in six patients
after TAVI. In addition, after TAVI, patients with AF had signiﬁcantly higher PWD
than those without AF (p<0.001).
Conclusıon: PWD was found to be signiﬁcantly higher in AS due to pressure over-
load. After TAVI, decreasing atrial pressure can be changes atrial repolarization and
reduce the risk of AF. PWD could be useful predictor for the development of AF after
TAVI.ERS C233
